I did a brief email Q&A interview with Dr. Bob Lanza of Advanced Cell Technology (ACT) on their new hES MSCs pre-clinical data for Multiple Sclerosis. I discussed the paper itself in a concise review yesterday here. Thanks to Dr. Lanza for doing the interview. 1. Were you surprised at the fact that the therapeutic […]
Interview with Bob Lanza on new ACT MSCs for MS paper Read More »
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of
Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »
Fox News reports (and the Las Vegas Review-Journal too) that convicted stem cell fraud Alfred Sapse (see more on him & this case here and here) has been sentenced to 17 years in federal prison and ordered to pay more than $1 million in restitution. Sapse along with pediatrician Ralph Conti (see image above from the
Long prison sentence for another stem cell fraud Read More »
Lately on average patients or patient relatives contact me about stem cells more than once a week. That’s about 50 times a year. The patients or their parents have questions about stem cells most often. Sometimes they have comments about this blog. Other times they ask for medical advice from me. Because I am a
Contemplating patients contacting me about stem cells Read More »
In about a month my new book, Stem Cells: An Insider’s Guide, should be available as an e-book from the publisher and from Amazon. It’s available for pre-order now at Amazon here. The “real” book (i.e. the one made of paper) should be available in September. The book costs $29. Any writers out there interested in doing
Stem Cells An Insider’s Guide: More on My New Book Read More »
A new paper suggests a hopeful short-term safety profile of laboratory-grown stem cells for treatment of arthritis, but there are some important limitations to the study too. A debate continues to bubble over whether to classify laboratory-propagated stem cells as biological drugs. A persistent issue has been whether the growth of stem cells in culture
Short-term safety of lab-grown stem cells for arthritis: encouraging, but key caveats Read More »
One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You
Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »
Dutch Wat zijn stamcellen? Het menselijk lichaam bestaat uit honderden verschillende celtypes welke stuk voor stuk essentieel zijn voor onze gezondheid. Deze cellen zijn ervoor verantwoordelijk dat ons lichaam gezond functioneert door onze hartslag te reguleren, onze hersenactiviteiten te reguleren, onze huid kan afschilferen, etc. etc. De unieke taak van stamcellen is dat ze elk
Wat is een stamcel? Read More »
Back-to-back papers (here and here) in Nature Biotechnology report the transdifferentiation (now often simply referred to as “direct reprogramming”) of plain old fibroblasts into brain cells called oligodendrocyte progenitor cells (OPCs). OPCs are a remarkably useful kind of brain cell that generates myelin, which insulates nerves. OPCs are thought to have great therapeutic potential for
The Vatican Stem Cell Meeting 2013 has started. We are fortunate to have a guest blogger, John A. Carbona, CEO of BioLife Cell Bank, who is in attendance and kindly is giving us inside coverage of the meeting. Below is a guest blog from John on Day 1 of the meeting. We even have pictures.
Guest blog from inside Vatican Stem Cell Meeting by John Carbona: Day 1 Read More »